Survival analysis of immune-related lncRNA in low-grade glioma

BACKGROUND: Low-grade glioma is grade I-II glioma. Immunotherapy is a promising way of tumor killing. Research on immune molecular mechanisms in low-grade gliomas and discovery of new immune checkpoints for low-grade gliomas are of great importance. METHODS: Gene sequencing data and clinical data of...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiaozhi, Meng, Yutong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6697914/
https://www.ncbi.nlm.nih.gov/pubmed/31419958
http://dx.doi.org/10.1186/s12885-019-6032-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6697914/
https://www.ncbi.nlm.nih.gov/pubmed/31419958
http://dx.doi.org/10.1186/s12885-019-6032-3

Ejemplares similares